Deener: After three-year run, biotech stocks take a beating

Home › Deener: After three-year run, biotech stocks take a beating

Joel Roth, 65, of San Rafael, Calif., is taking Sovaldi for hepatitis c. It costs $1,000 per pill, or $84,000 for a 12-week treatment course.

05.07	Atlantic Tropical Weather Outlook
05.07	Eastern North Pacific Tropical Weather Outlook
04.07	Hurricane Beryl Graphics
04.07	Hurricane Beryl Forecast Discussion Number 25
04.07	Hurricane Beryl Public Advisory Number 25
04.07	Summary for Hurricane Beryl (AT2/AL022024)
04.07	Hurricane Beryl Wind Speed Probabilities Number 25
04.07	Hurricane Beryl Forecast Advisory Number 25
More »

je.st